SCHEMBL6003238

SCHEMBL6003238

COc1ccc(-c2ncc[nH]2)c(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.55
SMPD3 Q9NY59 1/20 0.51
CYP1A1 P04798 2/20 0.49
CYP1B1 Q16678 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2E1 P05181 1/20 0.49
CYP2C8 P10632 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2A6 P11509 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP4B1 P13584 1/20 0.49
CYP2B6 P20813 1/20 0.49
CYP3A5 P20815 1/20 0.49
CYP2A7 P20853 1/20 0.49
CYP3A7 P24462 1/20 0.49
CYP2F1 P24903 1/20 0.49
CYP2C18 P33260 1/20 0.49
CYP2C19 P33261 1/20 0.49
CYP2J2 P51589 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31559158 0.89 SMPD3 (0.50) PDE2ASMPD3CYP1A2CYP3A4CYP2D6
SCHEMBL8541036 0.89 SMPD3 (0.50) PDE2ASMPD3CYP1A2CYP3A4CYP2D6
SCHEMBL10921944 0.84 SMPD3 (0.47) PDE2ASMPD3ALDH1A1MAPK1KDM4E
SCHEMBL8542548 0.83 ADRA2A (0.57) PDE2ASMPD3CYP1A2CYP3A4CYP2D6
SCHEMBL11203475 0.83 NOTUM (0.54) SMPD3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9634823 0.83 MAOB (0.44) PDE2ASMPD3CYP1A2CYP3A4CYP2D6
SCHEMBL3633273 0.82 SMPD3 (0.50) SMPD3ALDH1A1GAAMAPK1HTT
SCHEMBL31429681 0.82 NOTUM (0.53) SMPD3ALDH1A1GAAMAPK1ADRA2A
SCHEMBL8540690 0.82 ADRA2A (0.46) SMPD3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6722647 0.82 AMY1A (0.55) SMPD3CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114315754-A Hydroxamic acid compound and application thereof 南方医科大学 2022-04-12 CN disclosed
CN-106699771-A Cryptotanshinone compound, as well as preparation method and application thereof 常州大学 2017-05-24 CN disclosed
CN-102712074-B Polishing pad TOYO TIRE & RUBBER CO.,LTD. (JP) 2016-01-20 CN disclosed
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed
EP-0857171-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1998-08-12 EP disclosed
WO-1997015555-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1997-05-01 WO disclosed
EP-0079083-A1 New imidazo[4,5-c]pyridine derivatives, processes for their preparation and pharmaceutical formulations containing such compounds MERCK PATENT GmbH (DE) 1983-05-18 EP disclosed